Age is a significant biomarker for the selection of neoadjuvant chemotherapy plus radiotherapy versus concurrent chemoradiotherapy in patients with advanced nasopharyngeal carcinoma

CONCLUSIONS: Age is a significant biomarker when selecting NACT + RT or CCRT alone in patients with advanced NPC.PMID:36938724 | DOI:10.3233/CBM-210357

Source: Cancer Biomarkers - March 20, 2023 Category: Cancer & Oncology Authors: Yihong Lin Xiongbin Yu Linbin Lu Hong Chen Junxian Wu Yaying Chen Qin Lin Xuewen Wang Xi Chen Xiong Chen Source Type: research